Emerging data suggest Retatru tide , a dual stimulator targeting both incretin and GIP , may represent a notable step forward for obesity treatment. Preliminary human trials have indicated https://getretatrutideaustralia.com/blog/retatrutide-weight-loss-revolution-2026